RN-1026

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameRN-1026
Drug Alias NameRN-1026RI-1026
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAppetite stimulants
TargetsUpdating
Therapy Area/IndicationsCachexiaDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRinat-Pfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRinat-Pfizer IncPfizer Inc
Active IndicationsN/A
Inactive IndicationsCachexiaDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A